Es la Revista Oficial de la Sociedad Española de Ginecología y Obstetricia, y está presente en los más prestigiosos índices de referencia en medicina. Sus contenidos, clasificados en función de 4 grandes áreas (reproducción y endocrinología, perinatología, oncología y ginecología general) resultan de máxima utilidad para el especialista.12 NÚMEROS AL AÑO + 2 EXTRAORDINARIOS CONGRESO BIANUALPara más información, consulte http://ees.elsevier.es/pog
Each issue of Progress in Cardiovascular Diseases comprehensively covers a single topic in the understanding and treatment of disorders of the heart and circulation. Some issues include special articles, definitive reviews that capture the state of the art in the management of particular clinical problems in cardiology.2012 Topics:Hypertrophic CardiomyopathyGuest Editor: Mark SherridInnovation in BiomarkersGuest Editor: Wilson TangPulmonary HypertensionGuest Editor: Evelyn HornEthics in CardiologyGuest Editor: Neal DickertSyncopeGuest Editors: David Cannom and David BendittBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
The mission of the Journal is to facilitate dissemination of programs that use community partnerships to improve public health, to promote progress in the methods of research and education involving community health partnerships, and to stimulate action that will improve the health of people in communities. Communities, as defined by the Journal, may be based on geography, shared interests, or social networks. The Journal is dedicated to supporting the work of community health partnerships that involve ongoing collaboration between community representatives and academic or governmental partners. This area of research and evaluation may be referred to as community-based participatory research (CBPR). The W. K. Kellogg Foundation defines CBPR as a collaborative approach to research that equitably involves all partners in the research process and recognizes the unique strengths that each brings. CBPR begins with a research topic of importance to the community and has the aim of combining knowledge with action and achieving social change to improve health outcomes and eliminate health disparities.
Progress in Histochemistry and Cytochemistry publishes comprehensive and analytical reviews within the entire field of histochemistry and cytochemistry. Methodological contributions as well as papers in the fields of applied histo- and cytochemistry (e.g. cell biology, pathology, clinical disciplines) will be accepted.
Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our
Please see our
Progress in Orthodontics is a fully open access journal owned by the Italian Society of Orthodontics and published under the brand SpringerOpen. It is a premier journal of international scope that fosters orthodontic research, including both basic research and development of innovative clinical techniques, with an emphasis on the following areas:- Mechanisms to improve orthodontics- Clinical studies and control animal studies- Orthodontics and genetics, genomics- Temporomandibular joint (TMJ) control clinical trials- Efficacy of orthodontic appliances and animal models- Systematic reviews and meta analyses- Mechanisms to speed orthodontic treatment Progress in Orthodontics will consider for publication only meritorious and original contributions. These may be: • Original articles reporting the findings of clinical trials, clinically relevant basic scientific investigations, or novel therapeutic or diagnostic systems • Review articles on current topics • Articles on novel techniques and clinical tools • Articles of contemporary interest Submitted manuscripts will be reviewed by at least two referees. All accepted articles are published free of charge.
The journal is now accepting original research observations, brief research reports, reviews, and letters to the Editor.
In addition, some issues and sections of the journal will continue to be prepared in collaboration with one or more Guest Editors. These special issues will focus on a single subject, allowing for comprehensive presentations of complex, multifaceted or rapidly changing topics of clinical and investigative interest.
P
By invitation leading experts write on basic and clinical aspects of the eye in a style appealing to molecular biologists, neuroscientists and physiologists, as well as to vision researchers and ophthalmologists.The journal covers all aspects of eye research, including topics pertaining to the retina and pigment pithelial layer, cornea, tears, lacrimal glands, aqueous humour, iris, ciliary body, trabeculum, lens, vitreous humour and diseases such as dry-eye, inflammation, keratoconus, corneal dystrophy, glaucoma and cataract.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
The Prostate is a peer-reviewed journal dedicated to original studies of this organ and the male accessory glands. It serves as an international medium for these studies, presenting comprehensive coverage of clinical, anatomic, embryologic, physiologic, endocrinologic, and biochemical studies.
Prostate Cancer is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of prostate cancer.
Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management.Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, BPH and prostatitis.Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases: * Alternative therapies * Angiogenesis * Anti-sense oligonucleotides against growth factors * Brachytherapy * Conformal radiotherapy * Cryotherapy * Cyclotron fast neutron treatment * Enhancing the results of radical prostatectomy * Epidemiology of prostate cancer and prostatic diseases * Familial prostate cancer * Free to total PSA * Gene therapy for prostate cancer * Genetic basis for prostate cancer Hormone-related disease * How significant is PSA-detected disease? * Intermittent antiandrogen therapy * Mechanisms of tumour invasion in prostate cancer * Medical and surgical therapies for BPH * Medical therapy for BPH: the road ahead * Natural history of prostate cancer and prostatic diseases * Nutrition in prostate cancer and prostatic diseases * Photodynamic therapy * Prognostic markers * Prostate cancer and potency and impotence * Prostatic intra-epithelial neoplasia - an important precursor of cancer * Prostatitis: quo vadis? * Quality of life issues * Racial issues in prostate cancer * Recurrence after radical prostatectomy * Reproducibility (test-retest reliability) of investigations for prostatic diseases * Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA * Role of differentiation therapy * Screening for prostate cancer * Staging of prostate cancer: beyond conventional imaging * The magic bullet - use of PSA promotor gene to target gene therapy * Utility of ultrasensitive PSA assays.